Extensive Phenotyping of Individuals at Risk for Familial Interstitial Pneumonia Reveals Clues to the Pathogenesis of Interstitial Lung Disease
Jonathan A. Kropski(Pulmonary and Allergy Associates), Timothy S. Blackwell(Vanderbilt University), Joseph F. Solus(Vanderbilt University), Joy D. Cogan(Vanderbilt University Medical Center), Jae Woo Lee(University of California, San Francisco), Linda A. Gleaves(Pulmonary and Allergy Associates), Cheryl Markin(Vanderbilt University), Lorraine B. Ware(TEPCO (Japan)), John A. Worrell(Vanderbilt University), Lisa Lancaster(Vanderbilt University Medical Center), Amber L. Degryse(Pulmonary and Allergy Associates), Melinda E. McConaha(Vanderbilt University), Rinat Zaynagetdinov(Vanderbilt University), Otis B. Rickman(Vanderbilt University), Eric S. White(University of Michigan–Ann Arbor), Leena Choi, Pierre P. Massion(Vanderbilt University), Peter F. Crossno, James E. Loyd, Jonathan D. Kurtis(Brown University), Joyce E. Johnson(Vanderbilt University), Donald F. Zoz(Boehringer Ingelheim (United States)), Errine T. Garnett(Pulmonary and Allergy Associates), Brittany R. Jones(Pulmonary and Allergy Associates), Steve D. Groshong(National Jewish Health), Jason M. Pritchett(Vanderbilt University), Vasiliy V. Polosukhin, William E. Lawson(VA Tennessee Valley Healthcare System), Dong-sheng Cheng(Vanderbilt University), Daphne B. Mitchell(Pulmonary and Allergy Associates), Mark P. Steele(Vanderbilt University), Frank B. McMahon(Pulmonary and Allergy Associates), Lisa R. Young(Children's Hospital of Philadelphia)
American Journal of Respiratory and Critical Care Medicine
November 12, 2014
Cited by 187
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
|New England Journal of Medicine|2007|1.4k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k